Implications of antibiotic exposure among children in low-income and middle income countries by Olaru, Ioana D. et al.
Commentary Article 
 
Implications of antibiotic exposure among children in LMICs 
 
Ioana D. Olaru1,2, Dan Kibuule3, Godman B4,5,6,7*  
 
1London School of Hygiene and Tropical Medicine, London, United Kingdom. Email: ioana-
diana.olaru@lshtm.ac.uk 
2Biomedical Research and Training Institute, Harare, Zimbabwe 
3Department of Pharmacy Practice and Policy, Faculty of Health Sciences, University of Namibia, 
Windhoek, Namibia. E-mail: dkibuule@unam.na 
4Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 
0RE, United Kingdom. Email: brian.godman@strath.ac.uk 
5Division of Clinical Pharmacology, Karolinska Institute, Karolinska University Hospital Huddinge, SE-
141 86, Stockholm, Sweden. Email: Brian.Godman@ki.se 
6Department of Pharmacy, Faculty of Health Sciences, Sefako Makgatho Health Sciences University, 
Pretoria, South Africa  
7Health Economics Centre, University of Liverpool Management School, Liverpool, UK. Email: 
Brian.Godman@liverpool.ac.uk 
 
*Author for correspondence: Strathclyde Institute of Pharmacy and Biomedical Sciences, University of 
Strathclyde, Glasgow G4 0RE, United Kingdom. Email:  Brian.godman@strath.ac.uk. Telephone: 
0141 548 3825. Fax: 0141 552 2562 and Division of Clinical Pharmacology, Karolinska Institute, 
Karolinska University Hospital Huddinge, SE-141 86, Stockholm, Sweden. Email: 
Brian.Godman@ki.se. Telephone + 46 8 58581068. Fax + 46 8 59581070 
 
(Accepted for publication Lancet Infectious Diseases) 
 
Fink and co-authors are to be congratulated on their analysis of current antibiotic exposures among 
children under five in low- and middle income countries (LMICs) across a range of common illnesses 
including coughs, fevers, diarrhoea and malaria (1). The authors believe this is the first study to 
comprehensively quantify children’s cumulative exposure to antibiotics in LMICs using a robust 
methodology obtaining nationally representative data at the household level as well as from all formal-
sector facilities. This is important with previous surveys having only limited coverage in low income 
settings particularly sub-Saharan African countries with the greatest incidence of infectious diseases 
globally (2, 3). In addition, there is appreciable self-purchasing of antibiotics in LMICs with issues of 
affordability and access, which can account for up to 93% of all dispensed antibiotics in some LMICs 
(4, 5), alongside considerable use of antibiotics in ambulatory versus hospital care (2). Antimicrobial 
resistance (AMR) is a growing public health problem threatening health and incomes, driven by high 
inappropriate prescribing and dispensing of antibiotics (1, 6-8). Antibiotic prescribing in children is 
particularly problematic with typically the highest rates seen in children under five years (1, 2). This is 
despite many infections such as upper respiratory tract infections (URTIs) including coughs being viral 
in origin and therefore not requiring an antibiotic, and antibiotics not recommended in children with 
malaria in the absence of other infections (1, 9, 10). However, pressure from parents enhances 
prescribing and dispensing of antibiotics for URTIs especially if there are long waiting times and 
expense to see a physician (11, 12). Antibiotics are also not typically needed for children with 
diarrhoea unless this is chronic in nature and dysentery is suspected with oral rehydration 
recommended first line treatment, with published studies suggesting that antibiotics are only typically 
required in 1 to 7% of cases (1). 
 
In the eight countries surveyed, i.e. Haiti, Kenya, Malawi, Namibia, Nepal, Senegal, Tanzania and 
Uganda, Fink et al found that 33% of children under five in these countries were reported to have 
experienced either a cough of fever in the past few weeks, highest in Haiti and lowest in Senegal, 
reflecting the high rate of infectious diseases in these countries (1). Encouragingly, 45.5% of children 
were taken to a health facility for treatment with only a fraction (15.5%) taken for treatment outside of 
a health facility. This is seen to reflect considerable educational and other efforts in previous years to 
encourage parents to seek professional care for infections as early as possible in order to minimize 
the risk of severe disease and potential mortality (1). However, this in turn has enhanced the 
prescribing of unnecessary antibiotics. The average number of prescriptions per visit was 0.67, 
highest for respiratory infections at 0.856 prescriptions per diagnosis and lowest for children with 
malaria at 0.296 (1). Prescription rates were lowest for medical doctors (0.48) and highest for clinical 
officers (0.71) and nurses (0.70), with amoxycillin and cotrimoxazole accounting for 75% of all 
antibiotic prescriptions (1). Utilisation and overall exposure rates are likely to be higher when actual 
self-purchasing rates for antibiotics in both formal and informal sectors are taken into consideration (1, 
4, 5). This is a concern suggesting that current antibiotic exposure among children in LMICs is 
extremely high, which needs to be urgently addressed to reduce future AMR rates.   
 
Potential strategies to address this mentioned by Fink et al and others include ensuring up-to-date 
guidelines are readily accessible in primary healthcare centres as this can be an issue along with 
potentially electronic clinical decision support tools and other educational interventions, enhancing the 
use of point-of-care diagnostic testing when this becomes affordable in routine care in LMICs, 
educational initiatives among pharmacists where this is a concern along with greater enforcement of 
regulations to limit self-purchasing. In addition, behavioural and communication programmes among 
parents as they can appreciably enhance prescribing and dispensing of antibiotics (1, 5, 9, 11, 13). 
Typically multiple initiatives have greater success than single initiatives (5). Among ambulatory care 
centres, a combination of prescribing metrics based on the AWaRe group of antibiotics could improve 
their appropriate use along with stewardship programmes (2). Published studies involving the co-
authors have demonstrated that adherence to guidelines is a better marker of the quality of antibiotic 
prescribing than measuring consumption figures in isolation (3, 14). 
 
In conclusion, Fink et al have provided robust data demonstrating high levels of antibiotic utilization in 
the under fives in LMICs. This needs to be urgently addressed to reduce current levels of AMR and 
should be part of country’s national action plans to reduce AMR rates.  
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